235 research outputs found
Assessment of the 2-D shallow water solver in OpenFOAM for application in modeling of tidal flows
Global statements to produce and implement evidence in the post-COVID-19 era provide a path forward for rehabilitation - A joint initiative of Cochrane Rehabilitation and the leading journals in the field
Functional textiles - from research and development to innovations and industrial uptake
Functional textiles are one of the most important fields in textile industry and textile materials science. They include breathable, heat and cold-resistant materials, ultra-strong fabrics (e.g. as reinforcement for composites), new flameretardant fabrics (e.g. intumescent materials), optimisation of textile fabrics for acoustic properties, etc. Functional textiles became more and more important materials for various applications and interest in them grew year by year; and more and more conferences are focused on functional textiles, as well as the events which are not only textile conferences but encompass various fields of Material Science. This paper presents a short overview about the European Materials Research Society 2014 Fall meeting conference Symposium M “Functional textiles - from research and development to innovations and industrial uptake” and the projects which participated as symposium co-organisers: the European Coordination Action 2BFUNTEX funded by the EC 7th Framework Programme NMP, the COST Action MP1105 on “Sustainable flame retardancy for textiles and related materials based on nanoparticles substituting conventional chemicals (FLARETEX)” and the COST Action MP1206 on “Electrospun Nano-fibres for bio inspired composite materials and innovative industrial applications”. © AUTEX
Global statements to produce and implement evidence in the post-COVID-19 era provide a path forward for rehabilitation. A joint initiative of Cochrane Rehabilitation and the leading journals in the field
Recommended from our members
Use of antibiotics and the prevalence of antibiotic-associated diarrhoea in patients with spinal cord injuries: an international, multi-centre study
BACKGROUND: Little is known about the use of antibiotics and the extent of antibiotic-associated diarrhoea (AAD) in patients with spinal cord injuries (SCIs).
AIMS: To record the use of antibiotics, establish the prevalence of AAD and Clostridium difficile infection (CDI), and assess if there was any seasonal variation in antibiotic use and incidence of AAD in patients with SCIs.
METHODS: A retrospective study was conducted in six European SCI centres between October 2014 and June 2015. AAD was defined as two or more watery stools (Bristol Stool Scale type 5, 6 or 7) over 24 h.
FINDINGS: In total, 1267 adults (median age 54 years, 30.7% female) with SCIs (52.7% tetraplegia, 59% complete SCI) were included in this study. Among the 215 (17%) patients on antibiotics, the top three indications for antibiotics were urinary tract infections (UTIs), infected pressure ulcers and other skin infections. Thirty-two of these 215 (14.9%) patients developed AAD and two patients out of the total study population (2/1267; 0.16%) developed CDI. AAD was more common in summer than in spring, autumn or winter (30.3% vs 3.8%, 7.4% and 16.9%, respectively; P<0.01). AAD was associated with age ≥65 years, tetraplegia, higher body mass index, hypoalbuminaemia, polypharmacy, multiple antibiotic use and high-risk antibiotic use. Summer and winter seasons and male sex were identified as independent predictors for the development of AAD.
CONCLUSION: This survey found that AAD is common in patients with SCIs, and UTI is the most common cause of infection. Summer and winter seasons and male sex are unique predictors for AAD. Both AAD and UTIs are potentially preventable; therefore, further work should focus on preventing the over-use of antibiotics, and developing strategies to improve hospital infection control measures
PAK6 Phosphorylates 14-3-3 gamma to Regulate Steady State Phosphorylation of LRRK2
Mutations in Leucine-rich repeat kinase 2 (LRRK2) are associated with Parkinson’s
disease (PD) and, as such, LRRK2 is considered a promising therapeutic target for
age-related neurodegeneration. Although the cellular functions of LRRK2 in health and
disease are incompletely understood, robust evidence indicates that PD-associated
mutations alter LRRK2 kinase and GTPase activities with consequent deregulation of
the downstream signaling pathways. We have previously demonstrated that one LRRK2
binding partner is P21 (RAC1) Activated Kinase 6 (PAK6). Here, we interrogate the
PAK6 interactome and find that PAK6 binds a subset of 14-3-3 proteins in a kinase
dependent manner. Furthermore, PAK6 efficiently phosphorylates 14-3-3γ at Ser59 and
this phosphorylation serves as a switch to dissociate the chaperone from client proteins
including LRRK2, a well-established 14-3-3 binding partner. We found that 14-3-3γ
phosphorylated by PAK6 is no longer competent to bind LRRK2 at phospho-Ser935,
causing LRRK2 dephosphorylation. To address whether these interactions are relevant in
a neuronal context, we demonstrate that a constitutively active form of PAK6 rescues the
G2019S LRRK2-associated neurite shortening through phosphorylation of 14-3-3γ. Our
results identify PAK6 as the kinase for 14-3-3γ and reveal a novel regulatory mechanism
of 14-3-3/LRRK2 complex in the brain
Cochrane rehabilitation: 2020 Annual report
during its fourth year of existence, cochrane rehabilitation went on to promote evidence-informed health decision-making in rehabilitation. in 2020, the outbreak of the coVid-19 pandemic has made it necessary to alter priorities. in these challenging times, cochrane rehabilitation has firstly changed its internal organisation and established a new relevant project in line with pandemic needs: the REH-COVER (Rehabilitation – coVid-19 evidence-based response) action. the aim was to focus on the timely collection, review and dissemination of summarised and synthesised evidence relating to COVID-19 and rehabilitation. Cochrane Rehabilitation REH-COVER action has included in 2020 five main initiatives: 1) rapid living systematic reviews on rehabilitation and coVid-19; 2) interactive living evidence map on rehabilitation and coVid-19; 3) definition of the research topics on “rehabilitation and COVID-19” in collaboration with the World Health Organization (WHO) rehabilitation programme; 4) Cochrane Library special collection on Coronavirus (COVID-19) rehabilitation; and 5) collaboration with COVID-END for the topics “rehabilitation” and “disability.” Furthermore, we are still carrying on five different special projects: Be4rehab; RCTRACK; definition of rehabilitation for research purposes; ebook project; and a prioritization exercise for Cochrane Reviews production. The Review Working Area continued to identify and “tag” the rehabilitation-relevant reviews published in the cochrane library; the publication Working area went on to publish Cochrane Corners, working more closely with the Cochrane Review Groups (CRGs) and Cochrane Networks, particularly with Cochrane Musculoskeletal, oral, skin and sensory Network; the Education Working area, the most damaged in 2020, tried to continue performing educational activities such as workshops in different online meetings; the Methodology Working area organized the third and fourth cochrane Rehabilitation Methodological (CRM) meetings respectively in Milan and Orlando; the Communication Working Area spread rehabilitation evidences through different channels and translated the contents in different languages
White book on physical and rehabilitation medicine (PRM) in Europe. Chapter 10. Science and research in PRM: Specificities and challenges
In the context of the White Book of Physical and Rehabilitation Medicine (PRM), this paper deals with Research, the future of PRM. PRM students and specialists are mainly involved in biomedical research, investigating the biological processes, the causes of diseases, their medical diagnosis, the evaluation of their consequences on functioning, disability and health and the effects of health interventions at an individual and a societal level. Most of the current PRM research, often interdisciplinary, originates from applied research which, using existing knowledge, is directed towards specific goals. Translational medical research, research and development, implementation research and clinical impact research are in this field. PRM physicians, mainly master or PhD students, are nowadays increasing their participation in basic research and in pre-clinical trials. PRM physicians are involved in primary research, which is an original first hand research, but also in secondary research, which is the analysis and interpretation of primary research publications in a field, with a specific methodology. Secondary research remains an important activity of the UEMS PRM section and it will be the field of the new created Cochrane Rehabilitation. Secondary research with interest for persons with disabilities, will be developed world wide on the basis of evidence based medicine, with the participation of PRM physicians and of all other health and social professionals involved in rehabilitation. The development of research activities with interest for PRM in Europe is a challenge for the future, which has to be faced now. The European PRM schools, the European master and PhD program with their supporting research and clinical facilities, the European PRM organizations with their websites, the PRM scientific journals and European congresses are a strong basis to develop research activities, together with the development of Cochrane Rehabilitation field and of our cooperation with European high level research facilities, European and international scientific societies in different fields. PRM will be a leader in this field of research
Self-harm in young people with perinatal HIV and HIV negative young people in England: cross sectional analysis.
BACKGROUND: Self-harm in adolescents is of growing concern internationally but limited evidence exists on the prevalence of self-harm in those living with HIV, who may be at higher risk of poor mental health outcomes. Therefore our aim was to determine the prevalence and predictors of self-harm among young people with perinatally-acquired HIV (PHIV) and HIV negative (with sibling or mother living with HIV) young people living in England. METHODS: 303 PHIV and 100 HIV negative young people (aged 12-23 years) participating in the Adolescents and Adults Living with Perinatal HIV cohort study completed an anonymous self-harm questionnaire, as well as a number of standardised mental-health assessments. Logistic regression investigated predictors of self-harm. RESULTS: The median age was 16.7 years in both groups, and 40.9% of the PHIV and 31.0% of the HIV negative groups were male. In total 13.9% (56/403) reported having ever self-harmed, with no difference by HIV status (p = 0.089). Multivariable predictors of self-harm were female sex (adjusted odds ratio (AOR) 5.3, (95% confidence interval 1.9, 14.1), p = 0.001), lower self-esteem (AOR 0.9 (0.8, 0.9) per 1 point increase, p < 0.001) and having ever used alcohol (AOR 3.8 (1.8, 7.8), p < 0.001). Self-esteem z-scores for both PHIV and HIV negative participants were 1.9 standard deviations below the mean for population norms. CONCLUSIONS: Self-harm is common among PHIV and HIV negative adolescents in England. Reassuringly however, they do not appear to be at an increased risk compared to the general adolescent population (15-19% lifetime prevalence). The low level of self-esteem (compared to available normative data) in both groups is worrying and warrants further attention
- …